{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T07:34:37Z","timestamp":1793864077085,"version":"4.6.1"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,10,25]],"date-time":"2018-10-25T00:00:00Z","timestamp":1540425600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,10,25]],"date-time":"2018-10-25T00:00:00Z","timestamp":1540425600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Ischaemic stroke can occur when an artery to the brain is blocked by a blood clot. The use of thrombolytic agents, such as tissue plasminogen activator (tPA), to dissolve the occluding clot is limited by the risk of intracerebral haemorrhage (ICH), a known side effect associated with tPA. We developed a computational thrombolysis model for a 3D patient-specific artery coupled with a compartmental model for temporal concentrations of tPA and lysis proteins during intravenous infusion of tPA, in order to evaluate the effects of tPA dose on the efficacy of thrombolytic therapy and the risk of ICH. The model was applied to a 3-mm-long fibrin clot with two different fibrin fibre radii in the middle cerebral artery (MCA) \u2013 a setting relevant to ischaemic stroke, and results for different tPA dose levels and fibrin fibre radii were compared. Our simulation results showed that clot lysis was accelerated at higher tPA doses at the expense of a substantial increase in the risk of ICH. It was also found that a fine clot with a smaller fibre radius dissolved much slowly than a coarse clot due to a slower tPA penetration into the clots.<\/jats:p>","DOI":"10.1038\/s41598-018-34082-7","type":"journal-article","created":{"date-parts":[[2018,10,19]],"date-time":"2018-10-19T13:37:15Z","timestamp":1539956235000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Computational Simulations of Thrombolytic Therapy in Acute Ischaemic Stroke"],"prefix":"10.1038","volume":"8","author":[{"given":"Andris","family":"Piebalgs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boram","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dylan","family":"Roi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyriakos","family":"Lobotesis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Thom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8267-621X","authenticated-orcid":false,"given":"Xiao Yun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,25]]},"reference":[{"key":"34082_CR1","doi-asserted-by":"publisher","first-page":"2897","DOI":"10.1161\/01.CIR.103.24.2897","volume":"103","author":"AV Alexandrov","year":"2001","unstructured":"Alexandrov, A. V., Burgin, W. S., Demchuk, A. M., El-Mitwalli, A. & Grotta, J. C. Speed of intracranial clot lysis with intravenous tissue plasminogen activator therapy: sonographic classification and short-term improvement. Circulation 103, 2897\u20132902 (2001).","journal-title":"Circulation"},{"key":"34082_CR2","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1161\/STROKEAHA.110.612358","volume":"42","author":"O Adeoye","year":"2011","unstructured":"Adeoye, O., Hornung, R., Khatri, P. & Kleindorfer, D. Recombinant tissue-type plasminogen activator use for ischemic stroke in the United States: a doubling of treatment rates over the course of 5 years. Stroke 42, 1952\u20131955 (2011).","journal-title":"Stroke"},{"key":"34082_CR3","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1161\/STROKEAHA.116.012619","volume":"47","author":"J Minnerup","year":"2016","unstructured":"Minnerup, J. et al. Outcome after thrombectomy and intravenous thrombolysis in patients with acute ischemic stroke: a prospective observational study. Stroke 47, 1584\u20131592 (2016).","journal-title":"Stroke"},{"key":"34082_CR4","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1161\/STROKEAHA.117.017320","volume":"48","author":"EA Mistry","year":"2017","unstructured":"Mistry, E. A. et al. Mechanical thrombectomy outcomes with and without intravenous thrombolysis in stroke patient: a meta-analysis. Stroke 48, 2450\u20132456 (2017).","journal-title":"Stroke"},{"key":"34082_CR5","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/clpt.1989.120","volume":"46","author":"P Tanswell","year":"1989","unstructured":"Tanswell, P., Seifried, E., Su, P. C., Feuerer, W. & Rijken, D. C. Pharmacokinetics and systemic effects of tissue-type plasminogen activator in normal subjects. Clinical Pharmacology & Therapeutics 46, 155\u2013162 (1989).","journal-title":"Clinical Pharmacology & Therapeutics"},{"key":"34082_CR6","doi-asserted-by":"crossref","unstructured":"National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. New England Journal of Medicine 333 1581\u20131588 (1995).","DOI":"10.1056\/NEJM199512143332401"},{"key":"34082_CR7","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1001\/jama.1995.03530130023023","volume":"274","author":"W Hacke","year":"1995","unstructured":"Hacke, W. et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke: the European Cooperative Acute Stroke Study (ECASS). JAMA 274, 1017\u20131025 (1995).","journal-title":"JAMA"},{"key":"34082_CR8","first-page":"115","volume":"1","author":"Y Dong","year":"2016","unstructured":"Dong, Y. et al. Low-dose intravenous tissue plasminogen activator for acute ischaemic stroke: an alternative or a new standard? Stroke and Vascular. Neurology 1, 115\u2013121 (2016).","journal-title":"Neurology"},{"key":"34082_CR9","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1161\/STROKEAHA.110.589606","volume":"41","author":"J Nakagawara","year":"2010","unstructured":"Nakagawara, J. et al. Thrombolysis with 0.6 mg\/kg intravenous alteplase for acute ischemic stroke in routine clinical practice: the Japan post-Marketing Alteplase Registration Study (J-MARS). Stroke 41, 1984\u20131989 (2010).","journal-title":"Stroke"},{"key":"34082_CR10","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1161\/01.CIR.94.4.763","volume":"94","author":"S Anand","year":"1996","unstructured":"Anand, S. & Diamond, S. L. Computer simulation of systemic circulation and clot lysis dynamics during thrombolytic therapy that accounts for inner clot transport and reaction. Circulation 94, 763\u2013774 (1996).","journal-title":"Circulation"},{"key":"34082_CR11","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1002\/bit.10127","volume":"77","author":"DM Wootton","year":"2002","unstructured":"Wootton, D. M., Popel, A. S. & Rita Alevriadou, B. An experimental and theoretical study on the dissolution of mural fibrin clots by tissue type plasminogen activator. Biotechnology and Bioengineering 77, 405\u2013419 (2002).","journal-title":"Biotechnology and Bioengineering"},{"key":"34082_CR12","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1088\/0031-9155\/47\/2\/303","volume":"47","author":"CP Pleydell","year":"2002","unstructured":"Pleydell, C. P., David, T., Smye, S. W. & Berridge, D. C. A mathematical model of post-canalization thrombolysis. Physics in Medicine & Biology 47, 209 (2002).","journal-title":"Physics in Medicine & Biology"},{"key":"34082_CR13","doi-asserted-by":"publisher","first-page":"2969","DOI":"10.1088\/0031-9155\/52\/11\/003","volume":"52","author":"I Ser\u0161a","year":"2007","unstructured":"Ser\u0161a, I. et al. Modelling the effect of laminar axially directed blood flow on the dissolution of non-occlusive blood clots. Physics in Medicine & Biology 52, 2969 (2007).","journal-title":"Physics in Medicine & Biology"},{"key":"34082_CR14","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1016\/j.bpj.2013.01.029","volume":"104","author":"F Bajd","year":"2013","unstructured":"Bajd, F. & Sersa, I. Mathematical modeling of blood clot fragmentation during flow-mediated thrombolysis. Biophysical Journal 104, 1181\u20131190 (2013).","journal-title":"Biophysical Journal"},{"key":"34082_CR15","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1093\/imammb\/dqs029","volume":"33","author":"BE Bannish","year":"2014","unstructured":"Bannish, B. E., Keener, J. P. & Fogelson, A. L. Modelling fibrinolysis: a 3D stochastic multiscale model. Mathematical Medicine and Biology 33, 17\u201344 (2014).","journal-title":"Mathematical Medicine and Biology"},{"key":"34082_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-06383-w","volume":"7","author":"BE Bannish","year":"2017","unstructured":"Bannish, B. E., Chernysh, I. N., Kenner, J. P., Fogelson, A. L. & Weisel, J. W. Molecular and physical mechanisms of fibrinolysis and thrombolysis from mathematical modelling and experiments. Scientific Reports 7, 1\u201311 (2017).","journal-title":"Scientific Reports"},{"key":"34082_CR17","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1002\/(SICI)1099-081X(199803)19:2<131::AID-BDD87>3.0.CO;2-L","volume":"19","author":"KR Godfrey","year":"1998","unstructured":"Godfrey, K. R., Tanswell, P., Bates, R. A., Chappell, M. J. & Madden, F. N. Nonlinear pharmacokinetics of tissue\u2010type plasminogen activator in three animal species: a comparison of mathematical models. Biopharmaceutics & drug disposition 19, 131\u2013140 (1998).","journal-title":"Biopharmaceutics & drug disposition"},{"key":"34082_CR18","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/clpt.1987.31","volume":"41","author":"DA Noe","year":"1987","unstructured":"Noe, D. A. & Bell, W. R. A kinetic analysis of fibrinogenolysis during plasminogen activator therapy. Clinical Pharmacology & Therapeutics 41, 297\u2013303 (1987).","journal-title":"Clinical Pharmacology & Therapeutics"},{"key":"34082_CR19","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1161\/01.CIR.73.6.1291","volume":"73","author":"AJ Tiefenbrunn","year":"1986","unstructured":"Tiefenbrunn, A. J. et al. Pharmacodynamics of tissue-type plasminogen activator characterized by computer-assisted simulation. Circulation 73, 1291\u20131299 (1986).","journal-title":"Circulation"},{"key":"34082_CR20","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1177\/1538574413497107","volume":"47","author":"N Skeik","year":"2013","unstructured":"Skeik, N., Gits, C. C., Ehrenwald, E. & Cragg, A. H. Fibrinogen level as a surrogate for the outcome of thrombolytic therapy using tissue plasminogen activator for acute lower extremity intravascular thrombosis. Vascular and Endovascular Surgery 47, 519\u2013523 (2013).","journal-title":"Vascular and Endovascular Surgery"},{"key":"34082_CR21","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.jstrokecerebrovasdis.2014.09.005","volume":"24","author":"L Vandelli","year":"2015","unstructured":"Vandelli, L. et al. Fibrinogen decrease after intravenous thrombolysis in ischemic stroke patients is a risk factor for intracerebral hemorrhage. Journal of Stroke and Cerebrovascular Diseases 24, 394\u2013400 (2015).","journal-title":"Journal of Stroke and Cerebrovascular Diseases"},{"key":"34082_CR22","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/9781118833391.ch13","volume-title":"Hemostasis and Thrombosis","author":"John W. Weisel","year":"2014","unstructured":"Weisel, J. W. & Litvinov, R. I. Mechanisms of fibrinolysis and basic principles of management. Hemostasis and Thrombosis 169\u2013185; https:\/\/doi.org\/10.1002\/9781118833391.ch13 (2014)."},{"key":"34082_CR23","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.1161\/01.STR.0000230307.03438.94","volume":"37","author":"VJ Marder","year":"2006","unstructured":"Marder, V. J. et al. Analysis of thrombi retrieved from cerebral arteries of patients with acute ischemic stroke. Stroke 37, 2086\u20132093 (2006).","journal-title":"Stroke"},{"key":"34082_CR24","doi-asserted-by":"publisher","first-page":"20150949","DOI":"10.1098\/rsif.2015.0949","volume":"12","author":"A Piebalgs","year":"2015","unstructured":"Piebalgs, A. & Xu, X. Y. Towards a multi-physics modelling framework for thrombolysis under the influence of blood flow. Journal of the Royal Society Interface 12, 20150949 (2015).","journal-title":"Journal of the Royal Society Interface"},{"key":"34082_CR25","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1016\/j.bpj.2013.02.055","volume":"104","author":"AR Wufsus","year":"2013","unstructured":"Wufsus, A. R., Macera, N. E. & Neeves, K. B. The hydraulic permeability of blood clots as a function of fibrin and platelet density. Biophysical Journal 104, 1812\u20131823 (2013).","journal-title":"Biophysical Journal"},{"key":"34082_CR26","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1055\/s-0038-1648820","volume":"72","author":"J-H Wu","year":"1994","unstructured":"Wu, J.-H., Siddiqui, K. & Diamond, S. L. Transport phenomena and clot dissolving therapy: an experimental investigation of diffusion-controlled and permeation-enhanced fibrinolysis. Thrombosis and Haemostasis 72, 105\u2013112 (1994).","journal-title":"Thrombosis and Haemostasis"},{"key":"34082_CR27","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.1016\/S0006-3495(93)81314-6","volume":"65","author":"SL Diamond","year":"1993","unstructured":"Diamond, S. L. & Anand, S. Inner clot diffusion and permeation during fibrinolysis. Biophysical Journal 65, 2622\u20132643 (1993).","journal-title":"Biophysical Journal"},{"key":"34082_CR28","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1109\/TBME.2014.2364522","volume":"62","author":"PJ Blanco","year":"2015","unstructured":"Blanco, P. J., Watanabe, S. M., Passos, M. A. R., Lemos, P. A. & Feij\u00f3o, R. A. An anatomically detailed arterial network model for one-dimensional computational hemodynamics. IEEE Transactions on biomedical engineering 62, 736\u2013753 (2015).","journal-title":"IEEE Transactions on biomedical engineering"},{"key":"34082_CR29","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s11517-008-0359-2","volume":"47","author":"N Westerhof","year":"2009","unstructured":"Westerhof, N., Lankhaar, J. W. & Westerhof, B. E. The arterial windkessel. Medical & biological engineering & computing 47, 131\u2013141 (2009).","journal-title":"Medical & biological engineering & computing"},{"key":"34082_CR30","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1146\/annurev.bioeng.1.1.427","volume":"1","author":"SL Diamond","year":"1999","unstructured":"Diamond, S. L. Engineering design of optimal strategies for blood clot dissolution. Annual Review of Biomedical Engineering 1, 427\u2013461 (1999).","journal-title":"Annual Review of Biomedical Engineering"},{"key":"34082_CR31","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1016\/j.bpj.2010.04.059","volume":"99","author":"C Yeromonahos","year":"2010","unstructured":"Yeromonahos, C., Polack, B. & Caton, F. Nanostructure of the fibrin clot. Biophysical Journal 99, 2018\u20132027 (2010).","journal-title":"Biophysical Journal"},{"key":"34082_CR32","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1161\/01.CIR.73.3.511","volume":"73","author":"D Collen","year":"1986","unstructured":"Collen, D., Bounameaux, H. E. N. R. I., De Cock, F., Lijnen, H. R. & Verstraete, M. Analysis of coagulation and fibrinolysis during intravenous infusion of recombinant human tissue-type plasminogen activator in patients with acute myocardial infarction. Circulation 73, 511\u2013517 (1986).","journal-title":"Circulation"},{"key":"34082_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/358640","volume":"2014","author":"Paul Acheampong","year":"2014","unstructured":"Acheampong, P., May, M. T., Ford, G. A. & Dixit, A. K. Bolus-infusion delays of alteplase during thrombolysis in acute ischaemic stroke and functional outcome at 3 months. Stroke Research and Treatment 2014 (2014).","journal-title":"Stroke Research and Treatment"},{"key":"34082_CR34","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1111\/j.1747-4949.2012.00924.x","volume":"9","author":"C Smith","year":"2014","unstructured":"Smith, C. et al. The influence of bolus to infusion delays on plasma Tissue Plasminogen Activator levels. International Journal of Stroke 9, 939\u2013942 (2014).","journal-title":"International Journal of Stroke"},{"key":"34082_CR35","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1055\/s-0038-1656374","volume":"68","author":"M Andrew","year":"1992","unstructured":"Andrew, M., Brooker, L., Leaker, M., Paes, B. & Weitz, J. Fibrin clot lysis by thrombolytic agents is impaired in newborns due to a low plasminogen concentration. Thrombosis and Haemostasis 68, 325\u2013330 (1992).","journal-title":"Thrombosis and Haemostasis"},{"key":"34082_CR36","first-page":"123","volume":"15","author":"DR Enzmann","year":"1994","unstructured":"Enzmann, D. R., Ross, M. R., Marks, M. P. & Pelc, N. J. Blood flow in major cerebral arteries measured by phase-contrast cine MR. American Journal of Neuroradiology 15, 123\u2013129 (1994).","journal-title":"American Journal of Neuroradiology"},{"key":"34082_CR37","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1007\/s003300000378","volume":"10","author":"KW Stock","year":"2000","unstructured":"Stock, K. W., Wetzel, S. G., Lyrer, P. A. & Rad\u00fc, E. W. Quantification of blood flow in the middle cerebral artery with phase-contrast MR imaging. European radiology 10, 1795\u20131800 (2000).","journal-title":"European radiology"},{"key":"34082_CR38","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1002\/jmri.1880040110","volume":"4","author":"HG Bogren","year":"1994","unstructured":"Bogren, H. G., Buonocore, M. H. & Gu, W. Z. Carotid and vertebral artery blood flow in left\u2010and right\u2010handed healthy subjects measured with MR velocity mapping. Journal of Magnetic Resonance Imaging 4, 37\u201342 (1994).","journal-title":"Journal of Magnetic Resonance Imaging"},{"key":"34082_CR39","first-page":"1","volume":"8","author":"BC Konala","year":"2011","unstructured":"Konala, B. C., Das, A. & Banerjee, R. K. Influence of arterial wall compliance on the pressure drop across coronary artery stenoses under hyperemic flow condition. Molecular & Cellular Biomechanics 8, 1\u201320 (2011).","journal-title":"Molecular & Cellular Biomechanics"},{"key":"34082_CR40","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1177\/1747493016641965","volume":"11","author":"SH Ahn","year":"2016","unstructured":"Ahn, S. H. et al. Histologic features of acute thrombi retrieved from stroke patients during mechanical reperfusion therapy. International Journal of Stroke 11, 1036\u20131044 (2016).","journal-title":"International Journal of Stroke"},{"key":"34082_CR41","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1161\/hh0402.105095","volume":"90","author":"JP Collet","year":"2002","unstructured":"Collet, J. P., Montalescot, G., Lesty, C. & Weisel, J. W. A structural and dynamic investigation of the facilitating effect of glycoprotein IIb\/IIIa inhibitors in dissolving platelet-rich clots. Circulation research 90, 428\u2013434 (2002).","journal-title":"Circulation research"},{"key":"34082_CR42","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1007\/BF02684132","volume":"25","author":"S Anand","year":"1997","unstructured":"Anand, S., Kudallur, V., Pitman, E. B. & Diamond, S. L. Mechanisms by which thrombolytic therapy results in nonuniform lysis and residual thrombus after reperfusion. Annals of Biomedical Engineering 25, 964\u2013974 (1997).","journal-title":"Annals of Biomedical Engineering"},{"key":"34082_CR43","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1182\/blood-2013-08-523860","volume":"123","author":"DB Cines","year":"2014","unstructured":"Cines, D. B. et al. Clot contraction: compression of erythrocytes into tightly packed polyhedra and redistribution of platelets and fibrin. Blood 123, 1596\u20131603 (2014).","journal-title":"Blood"},{"key":"34082_CR44","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1136\/jcp.34.9.979","volume":"34","author":"SA Cederholm-Williams","year":"1981","unstructured":"Cederholm-Williams, S. A. Concentration of plasminogen and antiplasmin in plasma and serum. Journal of Clinical Pathology 34, 979\u2013981 (1981).","journal-title":"Journal of Clinical Pathology"},{"key":"34082_CR45","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1111\/j.1365-2141.1972.tb05715.x","volume":"22","author":"D Collen","year":"1972","unstructured":"Collen, D., Tytgat, G. N., Claeys, H. & Piessens, R. Metabolism and distribution of fibrinogen. I. Fibrinogen turnover in physiological conditions in humans. British Journal of Haematology 22, 681\u2013700 (1972).","journal-title":"British Journal of Haematology"},{"key":"34082_CR46","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1172\/JCI106927","volume":"51","author":"D Collen","year":"1972","unstructured":"Collen, D., Tytgat, G., Claeys, H., Verstraete, M. & Wallen, P. Metabolism of plasminogen in healthy subjects: effect of tranexamic acid. Journal of Clinical Investigation 51, 1310\u20131318 (1972).","journal-title":"Journal of Clinical Investigation"},{"key":"34082_CR47","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/S0950-3536(05)80099-X","volume":"7","author":"NA Booth","year":"1994","unstructured":"Booth, N. A. & Bennett, B. Fibrinolysis and thrombosis. Bailliere\u2019s Clinical Haematology 7, 559\u2013572 (1994).","journal-title":"Bailliere\u2019s Clinical Haematology"},{"key":"34082_CR48","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1182\/blood.V53.2.313.313","volume":"53","author":"D Collen","year":"1979","unstructured":"Collen, D. & Wiman, B. Turnover of antiplasmin, the fast-acting plasmin inhibitor of plasma. Blood 53, 313\u2013324 (1979).","journal-title":"Blood"},{"key":"34082_CR49","first-page":"225","volume":"16","author":"R Lijnen","year":"1985","unstructured":"Lijnen, R. & Collen, D. Protease inhibitors of human plasma. \u03b1-2-antiplasmin. Journal of Medicine 16, 225\u2013284 (1985).","journal-title":"Journal of Medicine"},{"key":"34082_CR50","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1016\/j.bpj.2012.10.036","volume":"103","author":"KM Weigandt","year":"2012","unstructured":"Weigandt, K. M. et al. Fibrin clot structure and mechanics associated with specific oxidation of methionine residues in fibrinogen. Biophysical Journal 103, 2399\u20132407 (2012).","journal-title":"Biophysical Journal"},{"key":"34082_CR51","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1016\/S0021-9258(17)43319-9","volume":"259","author":"C Zamarron","year":"1984","unstructured":"Zamarron, C., Lijnen, H. R. & Collen, D. Kinetics of the activation of plasminogen by natural and recombinant tissue-type plasminogen activator. The Journal of Biological Chemistry 259, 2080\u20132083 (1984).","journal-title":"The Journal of Biological Chemistry"},{"key":"34082_CR52","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1002\/bit.10127","volume":"77","author":"DM Wootton","year":"2002","unstructured":"Wootton, D. M., Popel, A. S. & Rita Alevriadou, B. An experimental and theoretical study on the dissolution of mural fibrin clots by tissue\u2010type plasminogen activator. Biotechnology and Bioengineering 77, 405\u2013419 (2002).","journal-title":"Biotechnology and Bioengineering"},{"key":"34082_CR53","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1182\/blood.V74.3.999.999","volume":"74","author":"SS Husain","year":"1989","unstructured":"Husain, S. S., Hasan, A. A. & Budzynski, A. Z. Differences between binding of one-chain and two-chain tissue plasminogen activators to non-cross-linked and cross-linked fibrin clots. Blood 74, 999\u20131006 (1989).","journal-title":"Blood"},{"key":"34082_CR54","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1182\/blood.V79.6.1420.1420","volume":"79","author":"S Kunitada","year":"1992","unstructured":"Kunitada, S., FitzGerald, G. A. & Fitzgerald, D. J. Inhibition of clot lysis and decreased binding of tissue-type plasminogen activator as a consequence of clot retraction. Blood 79, 1420\u20131427 (1992).","journal-title":"Blood"},{"key":"34082_CR55","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1016\/S0021-9258(19)81051-7","volume":"257","author":"M Hoylaerts","year":"1982","unstructured":"Hoylaerts, M., Rijken, D. C., Lijnen, H. R. & Collen, D. Kinetics of the activation of plasminogen by human tissue plasminogen activator. Role of fibrin. The Journal of Biological Chemistry 257, 2912\u20132919 (1982).","journal-title":"Role of fibrin. The Journal of Biological Chemistry"},{"key":"34082_CR56","doi-asserted-by":"crossref","first-page":"4249","DOI":"10.1016\/S0021-9258(18)32614-0","volume":"258","author":"MA Lucas","year":"1983","unstructured":"Lucas, M. A., Fretto, L. J. & McKee, P. A. The binding of human plasminogen to fibrin and fibrinogen. Journal of Biological Chemistry 258, 4249\u20134256 (1983).","journal-title":"Journal of Biological Chemistry"},{"key":"34082_CR57","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1161\/01.CIR.87.6.1915","volume":"87","author":"GDO Lowe","year":"1993","unstructured":"Lowe, G. D. O. et al. Blood viscosity, fibrinogen, and activation of coagulation and leukocytes in peripheral arterial disease and the normal population in the Edinburgh Artery Study. Circulation 87, 1915\u20131920 (1993).","journal-title":"Circulation"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-34082-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-34082-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-34082-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T10:48:44Z","timestamp":1671619724000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-34082-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,25]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["34082"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-34082-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,25]]},"assertion":[{"value":"18 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"15810"}}